$XBI $168.01 -2% 📉
PIPELINE:
$PLX -11% Phase 3 data from BRIDGE trial of pegunigalsidase alfa (PRX–102) treating Fabry Disease. source
$VNDA +9% Reported Q4 20 sales and pipeline updates. source
FINANCIAL:
$SAVA -14% Offering
$ACET +22% Prices offering $13/sh
$TVTX -4% Offering
TMXD -15% Offering
$KDMN -7% Offering